Key result
The Amphiascore performed as well as the Euroscore in predicting in-hospital death among patients undergoing CABG or valve surgery, with both models achieving an AUC of 0.84.
Why the study?
Does the Amphiascore predict in-hospital death, MACE, and extended intensive care unit duration as well as the Euroscore in patients undergoing CABG or valve surgery?
Cohort (n=7,282)
Does the Amphiascore predict in-hospital death, MACE, and extended intensive care unit duration as well as the Euroscore in patients undergoing CABG or valve surgery?
Effect estimate: AUC 0.84
The newly developed Amphiascore performs comparably to the Euroscore for predicting in-hospital mortality after CABG or valve surgery, and provides additional models for predicting MACE and extended ICU stay.
No takes yet. Share an insight, caveat, or question.
Amphiascore may match Euroscore for mortality prediction after CABG or valve surgery; extends risk models but leaves open external validation.
Huijskes et al. (2003) conducted a cohort in Coronary artery bypass grafting (CABG) and/or heart valve operation (n=7,282). Amphiascore vs. Euroscore was evaluated on In-hospital death (AUC 0.84). The Amphiascore performed as well as the Euroscore in predicting in-hospital death among patients undergoing CABG or valve surgery, with both models achieving an AUC of 0.84.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: